Document Detail


Pretreatment performance status and nutrition are associated with early mortality of locally advanced head and neck cancer patients undergoing concurrent chemoradiation.
MedLine Citation:
PMID:  23188165     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Unexpected fatal events in patients with head and neck cancers undergoing concurrent chemoradiation therapy are a clinical concern. Malnutrition, which is reported frequently in head and neck cancer patients, are associated with immunity derangement. The purpose of this study was to identify risk factors for early death of patients undergoing chemoradiation. We retrospectively analyzed the records of 194 stage III, IVA, and IVB head and neck cancer patients who were treated with chemoradiation between 2007 and 2009. We defined early death as death while receiving chemoradiation or within 60 days of treatment completion. Risk factors for early death were tested using univariate and multivariate analyses. Fourteen patients (7.2 %) experienced early death, 78.6 % of whom died of infection. Univariate analysis revealed significant correlations between early death and several pretreatment variables, including Eastern Cooperative Oncology Group performance status (PS) >1, hemoglobin <10 g/dL, albumin <3 g/dL, body mass index (BMI) <19 kg/m(2), and peripheral blood total lymphocyte count <700/μL. Multivariate analysis showed that PS >1, BMI <19 kg/m(2), and peripheral blood total lymphocyte count <700/μL were independent variables associated with early death. Poor performance status and malnutrition before chemoradiation independently predict early death in locally advanced head and neck cancer patients undergoing chemoradiation. Cautious management of head and neck cancer patients with these risk factors is required throughout chemoradiation period.
Authors:
Pei-Hung Chang; Kun-Yun Yeh; Jen-Seng Huang; Chien-Hong Lai; Tsung-Han Wu; Yii-Jenq Lan; Jason Chien-Sheng Tsai; Eric Yen-Chao Chen; Shih-Wei Yang; Cheng-Hsu Wang
Related Documents :
23425165 - Selection criteria for lung-cancer screening.
15480815 - Treatment of cancer-related pain with transdermal buprenorphine: a report of three cases.
23702885 - Risk of mesothelioma following external beam radiotherapy for prostate cancer: a cohort...
23246035 - Selected adverse events in cancer patients treated with vascular endothelial growth fac...
17367815 - Peritoneal fluids from patients with certain gynecologic tumor contain elevated levels ...
23558355 - Analysis of occupational asbestos exposure and lung cancer mortality using the g formula.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-28
Journal Detail:
Title:  European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery     Volume:  -     ISSN:  1434-4726     ISO Abbreviation:  Eur Arch Otorhinolaryngol     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9002937     Medline TA:  Eur Arch Otorhinolaryngol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Hematology/Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung and Chang Gung University, College of Medicine, 200, Lane 208, Jijin 1st Road, Keelung, 20445, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Change of prevalence and clinical aspects of fungal ball according to temporal difference.
Next Document:  The efficacy of sequential therapy using pazufloxacin followed by oral fluoroquinolones for treatmen...